* Cabaletta Bio Inc CABA.OQ reported a quarterly adjusted loss
of 45 cents per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 50 cents per share.
* Reported revenue was zero; analysts expected zero.
* Cabaletta Bio Inc's reported EPS for the quarter was a loss
of 45 cents.
* The mean earnings estimate of analysts had fallen by
about 3.1% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Cabaletta Bio Inc shares had fallen by 18.6% this quarter and
lost 43.9% so far this year.
* The company reported a quarterly loss of $11.14 million.
* Wall Street's median 12-month price target for Cabaletta Bio
Inc is $22.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated August 5 at 02:11 p.m. All
figures in US dollars unless otherwise stated